Selenium Supplementation Significantly Reduces Thyroid Autoantibody Levels in Patients with Chronic Autoimmune Thyroiditis: A Systematic Review and Meta-Analysis

Thyroid

Volumn 26, Issue 12, 2016, Pages 1681-1692

  Wichman, Johanna ^a,b   Winther, Kristian Hillert ^a,b   Bonnema, Steen Joop ^a,b   Hegedüs, Laszlo ^a,b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

chronic autoimmune thyroiditis; clinical effect; Hashimoto's thyroiditis; meta analysis; selenium supplementation; systematic review

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEVOTHYROXINE; MONOCYTE CHEMOTACTIC PROTEIN 1; PLACEBO; SELENIUM; SELENOMETHIONINE; SODIUM SELENITE; THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; THYROID PEROXIDASE ANTIBODY; TUMOR NECROSIS FACTOR; AUTOANTIBODY; IODIDE PEROXIDASE; THYROGLOBULIN;

ACUTE TOXICITY; ADVERSE OUTCOME; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED CLINICAL TRIAL (TOPIC); DRUG EFFECT; HAIR LOSS; HASHIMOTO DISEASE; HEADACHE; HUMAN; IMMUNOMODULATION; META ANALYSIS; MINERAL SUPPLEMENTATION; OUTCOME ASSESSMENT; POPULATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RASH; RISK FACTOR; STOMACH DISEASE; SYSTEMATIC REVIEW; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; AUTOIMMUNE THYROIDITIS; BLOOD; DIETARY SUPPLEMENT; IMMUNOLOGY; THYROID GLAND;

AUTOANTIBODIES; DIETARY SUPPLEMENTS; HUMANS; IODIDE PEROXIDASE; SELENIUM; THYROGLOBULIN; THYROID GLAND; THYROIDITIS, AUTOIMMUNE;

EID: 85006253371     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2016.0256     Document Type: Article

References (65)

1. Vanderpump MP 2011 The epidemiology of thyroid disease. Br Med Bull 99:39-51.
2. Carle A, Laurberg P, Pedersen IB, Knudsen N, Perrild H, Ovesen L, Rasmussen LB, Jørgensen T 2006 Epidemiology of subtypes of hypothyroidism in Denmark. Eur J En-docrinol 154:21-28.
3. Wiersinga WM 2014 Paradigm shifts in thyroid hormone replacement therapies for hypothyroidism. Nat Rev En-docrinol 10:164-174.
4. Thvilum M, Brandt F, Almind D, Christensen K, Brix TH, Hegedüs L 2013 Type and extent of somatic morbidity before and after the diagnosis of hypothyroidism. A nationwide register study. PLoS One 8:e75789.
5. Thvilum M, Brandt F, Almind D, Christensen K, Brix TH, Hegedüs L 2014 Increased psychiatric morbidity before and after the diagnosis of hypothyroidism: a nationwide register study. Thyroid 24:802-808.
6. Thvilum M, Brandt F, Brix TH, Hegedüs L 2014 Hy-pothyroidism is a predictor of disability pension and loss of labor market income: a Danish register-based study. J Clin Endocrinol Metab 99:3129-3135.
7. Thvilum M, Brandt F, Almind D, Christensen K, Hegedüs L, Brix TH 2013 Excess mortality in patients diagnosed with hypothyroidism: a nationwide cohort study of singletons and twins. J Clin Endocrinol Metab 98:1069-1075.
8. Brix TH, Kyvik KO, Hegedüs L 2000A population-based study of chronic autoimmune hypothyroidism in Danish twins. J Clin Endocrinol Metab 85:536-539.
9. Prummel MF, Strieder T, Wiersinga WM 2004 The environment and autoimmune thyroid diseases. Eur J En-docrinol 150:605-618.
10. Rayman MP 2012 Selenium and human health. Lancet 379:1256-1268.
11. Schomburg L, Köhrle J 2008 On the importance of selenium and iodine metabolism for thyroid hormone biosynthesis and human health. Mol Nutr Food Res 52:1235-1246.
12. Wu Q, Rayman M, Hongjun L, Schomburg L, Cui B, Gao C, Chen P, Zhuang G, Zhang Z, Peng X, Li H, Zhao Y, He X, Zeng G, Qin F, Hou P, Shi B 2015 Low population selenium status is associated with increased prevalence of thyroid disease. J Clin Endocrinol Metab 100:4037-4047.
13. Toulis KA, Anastasilakis AD, Tzellos TG, Goulis DG, Kouvelas D 2010 Selenium supplementation in the treatment of Hashimoto's thyroiditis: a systematic review and a meta-analysis. Thyroid 20:1163-1173.
14. Duntas LH, Mantzou E, Koutras DA 2003 Effects of a six month treatment with selenomethionine in patients with autoimmune thyroiditis. Eur J Endocrinol 148:389-393.
15. Turker O, Kumanlioglu K, Karapolat I, Dogan I 2006 Selenium treatment in autoimmune thyroiditis: 9-month follow-up with variable doses. J Endocrinol 190:151-156.
16. Gärtner R, Gasnier BC, Dietrich JW, Krebs B, Angstwurm MW 2002 Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. J Clin Endocrinol Metab 87:1687-1691.
17. Karanikas G, Schuetz M, Kontur S 2008 No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid 18:7-12.
18. van Zuuren E, Albusta A, Fedorowicz Z, Carter B, Pijl H 2013 Selenium supplementation for Hashimoto's thyroid-itis. Cochrane Database Syst Rev 6:CD010223.
19. Fan Y, Xu S, Zhang H, Cao W, Wang K, Chen G, Di H, Cao M, Liu C 2014 Selenium supplementation for autoimmune thyroiditis: a systematic review and meta-analysis. Int J Endocrinol 2014:904573.
20. Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, Norris S, Falck-Ytter Y, Glasziou P, DeBeer H, Jaeschke R, Rind D, Meerpohl J, Dahm P, Schünemann HJ 2011 GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 64: 383-394.
21. Guyatt GH, Oxman AD, Kunz R, Atkins D, Brozek J, Vist G, Alderson P, Glasziou P, Falck-Ytter Y, Schünemann HJ 2011 GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol 64:395-400.
22. Balshem H, Helfand M, Schünemann HJ, Oxman AD, Kunz R, Brozek J, Vist GE, Falck-Ytter Y, Meerpohl J, Norris S, Guyatt GH 2011 GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 64:401-406.
23. Guyatt GH, Oxman AD, Vist G, Kunz R, Brozek J, Alonso-Coello P, Montori V, Akl EA, Djulbegovic B, Falck-Ytter Y, Norris SL, Williams JW Jr, Atkins D, Meerpohl J, Schüne-mann HJ 2011 GRADE guidelines: 4. Rating the quality of evidence-study limitations (risk of bias). J Clin Epidemiol 64:407-415.
24. Guyatt GH, Oxman AD, Montori V, Vist G, Kunz R, Brozek J, Alonso-Coello P, Djulbegovic B, Atkins D, Falck-Ytter Y, Williams JWJr, Meerpohl J, Norris SL, Akl EA, Schünemann HJ 2011 GRADE guidelines: 5. Rating the quality of evidence-publication bias. J Clin Epidemiol 64:1277-1282.
25. Guyatt GH, Oxman AD, Kunz R, Brozek J, Alonso-Coello P, Rind D, Devereaux PJ, Montori VM, Freyschuss B, Vist G, Jaeschke R, Williams JW Jr, Murad MH, Sinclair D, Falck-Ytter Y, Meerpohl J, Whittington C, Thorlund K, Andrews J, Schünemann HJ 2011 GRADE guidelines 6. Rating the quality of evidence-imprecision. J Clin Epidemiol 64:1283-1293.
26. Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, Alonso-Coello P, Glasziou P, Jaeschke R, Akl EA, Norris S, Vist G, Dahm P, Shukla VK, Higgins J, Falck-Ytter Y, Schünemann HJ, Group GW 2011 GRADE guidelines: 7. Rating the quality of evidence-inconsistency. J Clin Epidemiol 64:1294-1302.
27. Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, Alonso-Coello P, Falck-Ytter Y, Jaeschke R, Vist G, Akl EA, Post PN, Norris S, Meerpohl J, Shukla VK, Nasser M, Schünemann HJ, Group GW 2011 GRADE guidelines: 8. Rating the quality of evidence-indirectness. J Clin Epidemiol 64:1303-1310.
28. Guyatt GH, Oxman AD, Sultan S, Glasziou P, Akl EA, Alonso-Coello P, Atkins D, Kunz R, Brozek J, Montori V, Jaeschke R, Rind D, Dahm P, Meerpohl J, Vist G, Berliner E, Norris S, Falck-Ytter Y, Murad MH, Schünemann HJ, Group GW 2011 GRADE guidelines: 9. Rating up the quality of evidence. J Clin Epidemiol 64:1311-1316.
29. Nacamulli D, Mian C, Petricca D, Lazzarotto F, Barollo S, Pozza D, Masiero S, Faggian D, Plebani M, Girelli ME, Mantero F, Betterle C 2010 Influence of physiological dietary selenium supplementation on the natural course of autoimmune thyroiditis. Clin Endocrinol (Oxf) 73:535-539.
30. Higgins JPT Green S, eds 2011 Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. Available at: http://handbook.cochrane. org (accessed May 15, 2015).
31. Pilli T, Cantara S, Schomburg L, Cenci V, Cardinale S, Heid EC, Kühn EC, Cevenini G, Sestini F, Fioravanti C, D'Hauw G, Pacini F 2015 IFNgamma-inducible chemo-kines decrease upon selenomethionine supplementation in women with euthyroid autoimmune thyroiditis: comparison between two doses of selenomethionine (80 or 160 lg) versus placebo. Eur Thyroid J 4:226-233.
32. Anastasilakis AD, Toulis KA, Nisianakis P, Goulis DG, Kampas L, Valeri RM, Oikonomou D, Tzellos TG, De-laroudis S 2012 Selenomethionine treatment in patients with autoimmune thyroiditis: a prospective, quasi-randomised trial. Int J Clin Pract 66:378-383.
33. Krysiak R, Okopien B 2011 The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cyto-kine release in women with Hashimoto's thyroiditis. J Clin Endocrinol Metab 96:2206-2215.
34. Krysiak R, Okopien B 2012 Haemostatic effects of le-vothyroxine and selenomethionine in euthyroid patients with Hashimoto's thyroiditis. Thromb Haemost 108:973-980.
35. Huedo-Medina TB, Sanchez-Meca J, Marin-Martinez F, Botella J 2006 Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods 11:193-206.
36. Balazs C 2008 [The effect of selenium therapy on autoimmune thyroiditis]. Orv Hetil 149:1227-1232.
37. Cenci V, Pilli T, Cardinale S 2013 Selenomethionine supplementation in euthyroid patients with autoimmune thy-roiditis. Eur Thyroid J 2:134.
38. Ciric S 2011 Effects of selenium supplementation on TPOAb in active autoimmune thyroiditis. Eur Thyroid J 1:136.
39. Duntas L, Boutsiadis A, Mantzou E 2013 Selenium supplementation in pregnant women with chronic autoimmune thyroiditis: effects on selenium, serum concentration and autoimmune parameters. Eur Thyroid J 2:92-93.
40. Guglielmi R, Misischi I, Graziano F 2013 Selenium supplementation in euthyroid patients with autoimmune thyroiditis. A pilot controlled study. Eur Thyroid J 2: 152.
41. Kvicala J, Hrda P, Zamrazil V 2010 Affects selenium indeed concentrations of serum autoantibodies TPOAb and TGAb? Trace Elem Electrolytes 27:167.
42. Mao J, Pop VJ, Bath SC, Vader HL, Redman CW, Ray-man MP 2016 Effect of low-dose selenium on thyroid autoimmunity and thyroid function in UK pregnant women with mild-to-moderate iodine deficiency. Eur J Nutr 55:55-61.
43. Negro R, Greco G, Mangieri T, Pezzarossa A, Dazzi D, Hassan H 2007 The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. J Clin Endocrinol Metab 92:1263-1268.
44. Nordio M, Pajalich R 2013 Combined treatment with Myo-inositol and selenium ensures euthyroidism in subclinical hypothyroidism patients with autoimmune thyroiditis. J Thyroid Res 2013:424163.
45. Zagrodzki P, Ratajczak R 2008 Selenium supplementation in autoimmune thyroiditis female patient-effects on thyroid and ovarian functions (case study). Biol Trace Elem Res 126:76-82.
46. Gärtner R, Gasnier BC 2003 Selenium in the treatment of autoimmune thyroiditis. Biofactors 19:165-170.
47. Kvicala J, Hrda P, Zamrazil V, Nemecek J, Hill M, Jiranek V 2009 Effect of selenium supplementation on thyroid antibodies. J Radioanal Nucl Chemi 280:275-279.
48. Bhuyan AK, Sarma D, Saikia UK 2012 Selenium and the thyroid: a close-knit connection. Indian J Endocrinol Metab 16:S354-355.
49. Mazokopakis EE, Papadakis JA, Papadomanolaki MG, Batistakis AG, Giannakopoulos TG, Protopapadakis EE, Ganotakis ES 2007 Effects of 12 months treatment with L-selenomethionine on serum anti-TPO levels in patients with Hashimoto's thyroiditis. Thyroid 17:609-612.
50. Zhu L, Bai X, Teng WP, Shan ZY, Wang WW, Fan CL, Wang H, Zhang HM 2012 [Effects of selenium supplementation on antibodies of autoimmune thyroiditis]. Zhonghua Yi Xue Za Zhi 92:2256-2260.
51. de Farias CR, Cardoso BR, de Oliveira GM, de Mello Guazzelli IC, Catarino RM, Chammas MC, Cozzolino SM, Knobel M 2015 A randomized-controlled, double-blind study of the impact of selenium supplementation on thyroid autoimmunity and inflammation with focus on the GPx1 genotypes. J Endocrinol Invest 38:1065-1074.
52. Eskes SA, Endert E, Fliers E, Birnie E, Hollenbach B, Schomburg L, Köhrle J, Wiersinga WM 2014 Selenite supplementation in euthyroid subjects with thyroid perox-idase antibodies. Clin Endocrinol (Oxf) 80:444-451.
53. Burk RF, Norsworthy BK, Hill KE, Motley AK, Byrne DW 2006 Effects of chemical form of selenium on plasma biomarkers in a high-dose human supplementation trial. Cancer Epidemiol Biomarkers Prev 15:804-810.
54. Gärtner R, Duntas LH 2008 Effects of selenium supplementation on TPOAb and cytokines in acute autoimmune thyroiditis. Thyroid 18:669-670; author reply 673-664.
55. Turker O, Karapolat I 2008 There is immunological benefit of selenium treatment in autoimmune thyroiditis. Thyroid 18:671-672.
56. Hegedüs L, Hansen JM, Feldt-Rasmussen U, Hansen BM, Høier-Madsen M 1991 Influence of thyroxine treatment on thyroid size and anti-thyroid peroxidase antibodies in Hashimoto's thyroiditis. Clin Endocrinol (Oxf) 35:235-238.
57. Schmidt M, Voell M, Rahlff I, Dietlein M, Kobe C, Faust M, Schicha H 2008 Long-term follow-up of antithyroid peroxidase antibodies in patients with chronic autoimmune thyroiditis (Hashimoto's thyroiditis) treated with levothy-roxine. Thyroid 18:755-760.
58. Mariotti S, Caturegli P, Piccolo P, Barbesino G, Pinchera A 1990 Antithyroid peroxidase autoantibodies in thyroid diseases. J Clin Endocrinol Metab 71:661-669.
59. Schulz KF, Altman DG, Moher D 2010 CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 340:c332.
60. Grange RD, Thompson JP, Lambert DG 2014 Radio-immunoassay, enzyme and non-enzyme-based immunoas-says. Br J Anaesth 112:213-216.
61. Nielsen CH, Brix TH, Gardas A, Banga JP, Hegedus L 2008 Epitope recognition patterns of thyroid peroxidase auto-antibodies in healthy individuals and patients with Hashimoto's thyroiditis. Clin Endocrinol (Oxf) 69:664-668.
62. Winther KH, Watt T, Bjørner JB, Cramon P, Feldt-Rasmussen U, Gluud C, Gram J, Groenvold M, Hegedus L, Knudsen N, Rasmussen AK, Bonnema SJ 2014 The chronic autoimmune thyroiditis quality of life selenium trial (CATALYST): study protocol for a randomized controlled trial. Trials 15:115.
63. Jablonska E, Vinceti M 2015 Selenium and human health: witnessing a Copernican revolution? J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 33:328-368.
64. Negro R, Attanasio R, Grimaldi F, Marcocci C, Guglielmi R, Papini E 2016A 2016 Italian survey about the clinical use of selenium in thyroid disease. Eur Thyroid J 5:164-170.
65. Hegedüs L, Bonnema SJ, Winther KH 2016 Selenium in the treatment of thyroid diseases. An element in search of the relevant indications? Eur Thyroid J 5:149-151.